CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants

被引：2
|
作者：
Villalba, N
Pérez-Olmeda, M
de José, M
Hernández, M
Sirera, R
Español, T
González-Molina, A
Soriano, V
机构：
[1] Inst Salud Carlos III, Infect Dis Serv, E-28010 Madrid, Spain
[2] Hosp La Paz, Serv Pediat, Madrid, Spain
[3] Hosp La Fe, Serv Immunol, E-46009 Valencia, Spain
[4] Hosp Vall Hebro, Serv Immunol, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1999年 / 18卷 / 05期
关键词：
D O I：
10.1007/PL00015029
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页码：389 / 391
页数：3
相关论文
共 50 条
  • [31] CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes
    Arthos, J
    Rubbert, A
    Rabin, RL
    Cicala, C
    Machado, E
    Wildt, K
    Hanbach, M
    Steenbeke, TD
    Swofford, R
    Farber, JM
    Fauci, AS
    JOURNAL OF VIROLOGY, 2000, 74 (14) : 6418 - 6424
  • [32] The fitness cost to human immunodeficiency virus type 1 of escaping from a small molecule CCR5 inhibitor
    Marozsan, Andre J.
    Matet, Alexandre
    Kuhmann, Shawn E.
    Rivera, Enid
    Morgan, Tom
    Arts, Eric J.
    Moore, John P.
    RETROVIROLOGY, 2005, 2 (Suppl 1)
  • [33] CCR5Δ32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo
    Agrawal, Lokesh
    Jin, Qingwen
    Altenburg, Jeff
    Meyer, L.
    Tubiana, R.
    Theodorou, Ioannis
    Alkhatib, Ghalib
    JOURNAL OF VIROLOGY, 2007, 81 (15) : 8041 - 8049
  • [34] Combined effect of CCR5-Δ32 heterozygosity and the CCR5 promoter polymorphism-2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission
    Hladik, F
    Liu, HL
    Speelmon, E
    Livingston-Rosanoff, D
    Wilson, S
    Sakchalathorn, P
    Hwangbo, Y
    Greene, B
    Zhu, TF
    McElrath, MJ
    JOURNAL OF VIROLOGY, 2005, 79 (18) : 11677 - 11684
  • [35] Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1
    Doranz, BJ
    Lu, ZH
    Rucker, J
    Zhang, TY
    Sharron, M
    Cen, YH
    Wang, ZX
    Guo, HH
    Du, JG
    Accaviti, MA
    Doms, RW
    Peiper, SC
    JOURNAL OF VIROLOGY, 1997, 71 (09) : 6305 - 6314
  • [36] The Fitness Cost to Human Immunodeficiency Virus Type 1 of Escaping From a Small Molecule CCR5 Inhibitor
    Andre J Marozsan
    Alexandre Matet
    Shawn E Kuhmann
    Enid Rivera
    Tom Morgan
    Eric J Arts
    John P Moore
    Retrovirology, 2
  • [37] CCR5 Δ32 deletion and reduced risk of toxoplasmosis in persons infected with human immunodeficiency virus type 1
    Meyer, L
    Magierowska, M
    Hubert, JB
    Mayaux, MJ
    Misrahi, M
    Le Chenadec, J
    Debre, P
    Rouzioux, C
    Delfraissy, JF
    Theodorou, I
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03): : 920 - 924
  • [38] Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1
    Keppler, OT
    Welte, FJ
    Ngo, TA
    Chin, PS
    Patton, KS
    Tsou, CL
    Abbey, NW
    Sharkey, ME
    Grant, RM
    You, Y
    Scarborough, JD
    Ellmeier, W
    Littman, DR
    Stevenson, M
    Charo, IF
    Herndier, BG
    Speck, RF
    Goldsmith, MA
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (06): : 719 - 736
  • [39] Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1
    Sellati, TJ
    Wilkinson, DA
    Sheffield, JS
    Koup, RA
    Radolf, JD
    Norgard, MV
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01): : 283 - 293
  • [40] Use of G-Protein-Coupled and -Uncoupled CCR5 Receptors by CCR5 Inhibitor-Resistant and -Sensitive Human Immunodeficiency Virus Type 1 Variants
    Berro, Reem
    Yasmeen, Anila
    Abrol, Ravinder
    Trzaskowski, Bartosz
    Abi-Habib, Sarya
    Grunbeck, Amy
    Lascano, Danny
    Goddard, William A., III
    Klasse, Per Johan
    Sakmar, Thomas P.
    Moore, John P.
    JOURNAL OF VIROLOGY, 2013, 87 (12) : 6569 - 6581
12345